Clinical Trial Update: NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study [NA]

View source ↗

Summary

A clinical trial update for the STRONG-DM study evaluating NT-ProBNP-based heart failure screening and prevention in patients with Type 2 diabetes; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Cardiomyopathy
• Heart Failure
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 2 Diabetes, Diabetic Cardiomyopathy | NA | Status: RECRUITING